SPRR2A is a potential mediator of therapeutic resistance and poor prognosis following definitive radiotherapy in head and neck cancerL. Nisa, M. Medova, M. Medo, M. Poliakova, J. Koch,B. Bojaxhiu,O. Elicin,R. Giger,U. Borner, M. Caversaccio,D. Aebersold,Y. ZimmerFEBS JOURNAL（2017）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
